J&J Invokana Suits Should Be An MDL, Patients Say
Patients suing Johnson & Johnson over harm to their kidneys allegedly caused by the company's Invokana diabetes drug asked the Judicial Panel on Multidistrict Litigation on Thursday to consolidate 56 individual...To view the full article, register now.
Already a subscriber? Click here to view full article